Prostaglandin analogs reducing intraocular pressure (IOP)

Name
Prostaglandin analogs reducing intraocular pressure (IOP)
Accession Number
DBCAT004677
Description

This category has been created to capture drug interactions between prostaglandin analogs reducing IOP.

Drugs
DrugDrug Description
LatanoprostAn isopropyl ester prodrug used to treat increased intraocular pressure.
TafluprostAn ophthalmic prostaglandin analog used to lower intraocular pressure in patients with ocular hypertension or open-angle glaucoma.
TravoprostA prostaglandin analog used in the treatment of elevated intraocular pressure due to open angle glaucoma or ocular hypertension.
Latanoprostene bunodA prostaglandin analog used to reduce ocular hypertension or treat open-angle glaucoma.
BimatoprostA prostaglandin analog used to treat hypotrichosis of the eyelashes and intraocular pressure in open angle glaucoma or ocular hypertension.
Drugs & Drug Targets
DrugTargetType
LatanoprostProstaglandin F2-alpha receptortarget
LatanoprostSolute carrier organic anion transporter family member 2A1transporter
LatanoprostSolute carrier family 22 member 6transporter
LatanoprostSolute carrier family 22 member 8transporter
LatanoprostCorneal esterasesenzyme
TafluprostProstaglandin F2-alpha receptortarget
TafluprostProstaglandin G/H synthase 2enzyme
TravoprostProstaglandin F2-alpha receptortarget
Latanoprostene bunodProstaglandin F2-alpha receptortarget
Latanoprostene bunodSolute carrier organic anion transporter family member 2B1transporter
BimatoprostProstaglandin F2-alpha receptortarget
BimatoprostProstaglandin E2 receptor EP1 subtypetarget
BimatoprostProstaglandin E2 receptor EP3 subtypetarget
BimatoprostCytochrome P450 3A4enzyme
BimatoprostCytochrome P450 3A5enzyme